Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.440 USD | -0.91% |
|
-2.33% | +59.53% |
Jun. 16 | CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances | RE |
Jun. 13 | Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target | MT |
Capitalization | 1.06B 1.22B 1B 909M 1.68B 106B 1.9B 11.85B 4.54B 48.6B 4.6B 4.5B 179B | P/E ratio 2025 * |
-10.4x | P/E ratio 2026 * | -9.68x |
---|---|---|---|---|---|
Enterprise value | 703M 810M 662M 602M 1.11B 70.18B 1.25B 7.84B 3B 32.15B 3.04B 2.98B 118B | EV / Sales 2025 * |
10.2x | EV / Sales 2026 * | 8.8x |
Free-Float |
54.74% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: CureVac N.V.
More recommendations
More press releases
More news
1 day | -0.91% | ||
1 week | -2.33% | ||
Current month | +21.70% | ||
1 month | +39.49% | ||
3 months | +88.24% | ||
6 months | +89.55% | ||
Current year | +59.53% |
1 week | 5.41 | ![]() | 5.58 |
1 month | 4 | ![]() | 5.72 |
Current year | 2.48 | ![]() | 5.72 |
1 year | 2.37 | ![]() | 5.72 |
3 years | 2.22 | ![]() | 15.62 |
5 years | 2.22 | ![]() | 151.8 |
10 years | 2.22 | ![]() | 151.8 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 2023-03-27 | |
Director of Finance/CFO | 58 | 2024-11-10 | |
Malte Greune
COO | Chief Operating Officer | 60 | 2021-06-30 |
Director | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 2015-07-31 | |
Mathias Hothum
BRD | Director/Board Member | 59 | 2015-07-31 |
Craig Tooman
BRD | Director/Board Member | 59 | 2019-05-31 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.91% | -2.33% | +66.87% | -61.64% | 1.22B | ||
+0.39% | -1.51% | +17.39% | +14.44% | 48.43B | ||
-2.25% | -8.36% | +58.27% | +61.84% | 29.32B | ||
+0.08% | -1.38% | -28.45% | -22.16% | 26.77B | ||
+1.25% | +0.87% | +0.01% | +19.62% | 26.16B | ||
-40.00% | +142.71% | +35,996.87% | +3,366.80% | 18.8B | ||
+0.10% | -1.36% | +12.82% | -18.13% | 12.32B | ||
-1.14% | -4.17% | +138.51% | - | 11.83B | ||
+2.02% | +0.56% | -54.05% | -28.64% | 11.64B | ||
+3.63% | +3.57% | +38.37% | +106.90% | 10.68B | ||
Average | -3.68% | +12.80% | +3,624.66% | +382.11% | 19.72B | |
Weighted average by Cap. | -3.63% | +11.71% | +3,449.14% | +357.32% |
2025 * | 2026 * | |
---|---|---|
Net sales | 69.05M 79.61M 65.04M 59.1M 109M 6.89B 123M 770M 295M 3.16B 299M 292M 11.61B | 85.64M 98.73M 80.67M 73.3M 136M 8.55B 153M 955M 366M 3.92B 370M 363M 14.4B |
Net income | -103M -119M -97.11M -88.23M -163M -10.29B -184M -1.15B -440M -4.72B -446M -436M -17.33B | -112M -129M -106M -95.94M -177M -11.19B -200M -1.25B -479M -5.13B -485M -475M -18.85B |
Net Debt | -360M -415M -339M -308M -570M -35.92B -642M -4.01B -1.54B -16.45B -1.56B -1.52B -60.48B | -309M -356M -291M -264M -489M -30.83B -551M -3.44B -1.32B -14.13B -1.34B -1.31B -51.92B |
More financial data
* Estimated data
Employees
904
Calendar
Jun. 24
- Annual General Meeting
Date | Price | Change | Volume |
---|---|---|---|
25-06-20 | 5.440 $ | -0.91% | 2,043,914 |
25-06-18 | 5.490 $ | -0.18% | 1,007,741 |
25-06-17 | 5.500 $ | -0.36% | 1,459,832 |
25-06-16 | 5.520 $ | -0.90% | 1,501,011 |
25-06-13 | 5.570 $ | -0.54% | 4,834,936 |
Delayed Quote Nasdaq, June 20, 2025 at 04:00 pm EDT
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
4.719EUR
Average target price
5.145EUR
Spread / Average Target
+9.03%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions